Glaucoma damages the optic nerve and is usually managed by reducing eye pressure, though treatment effects vary. Researchers have long suspected a link with homocysteine, but new findings reveal it is a bystander, not a driver of the disease.
Glaucoma damages the optic nerve and is usually managed by reducing eye pressure, though treatment effects vary. Researchers have long suspected a link with homocysteine, but new findings reveal it is a bystander, not a driver of the disease.